We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
869
Increased
2,214
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.45%
3 Consumer Discretionary 5.14%
4 Industrials 5.1%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRT
5126
DELISTED
HireRight Holdings Corporation
HRT
$164K ﹤0.01%
14,469
-91,751
-86% -$963K
LVTX
5127
DELISTED
LAVA Therapeutics
LVTX
$163K ﹤0.01%
+80,374
New +$148K
WOW
5128
DELISTED
WideOpenWest
WOW
$163K ﹤0.01%
19,326
-162,426
-89% -$1.47M
HDSN
5129
Hudson Technologies
HDSN
$248M
$162K ﹤0.01%
16,888
+6,540
+63% +$56.9K
GGROW
5130
CALL
Gogoro Inc Warrant
GGROW
$162K ﹤0.01%
386,313
AUPH icon
5131
Aurinia Pharmaceuticals
AUPH
$1.89B
$162K ﹤0.01%
16,731
-36,045
-68% -$374K
NEWP
5132
New Pacific Metals
NEWP
$849M
$162K ﹤0.01%
74,633
+27,864
+60% +$68.2K
QTTB icon
5133
Q32 Bio
QTTB
$461M
$161K ﹤0.01%
10,112
-1,537
-13% -$27.6K
CVM icon
5134
CEL-SCI Corp
CVM
$20.6M
$161K ﹤0.01%
2,225
-1,627
-42% -$118K
GBIO
5135
DELISTED
Generation Bio
GBIO
$161K ﹤0.01%
2,919
-1,013
-26% -$46.5K
BHIL.WS
5136
CALL
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$160K ﹤0.01%
808,525
BFX
5137
DELISTED
BowFlex Inc.
BFX
$159K ﹤0.01%
130,700
-20,529
-14% -$26.1K
CVAC
5138
CALL
DELISTED
CureVac
CVAC
$159K ﹤0.01%
+15,300
New +$137K
ASLE icon
5139
AerSale
ASLE
$292M
$159K ﹤0.01%
+10,842
New +$174K
MIR.WS
5140
CALL
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$159K ﹤0.01%
87,500
CLMT icon
5141
CALL
Calumet Specialty Products
CLMT
$3.74B
$159K ﹤0.01%
+10,000
New +$165K
PEPG icon
5142
PepGen
PEPG
$120M
$159K ﹤0.01%
17,730
+7,280
+70% +$95.2K
BTWNW
5143
CALL
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$158K ﹤0.01%
635,651
NAMSW icon
5144
CALL
NewAmsterdam Pharma Warrant
NAMSW
$76.9M
$157K ﹤0.01%
75,000
IPHA
5145
Innate Pharma
IPHA
$164M
$155K ﹤0.01%
49,450
-12,449
-20% -$38.3K
ORGN
5146
DELISTED
Origin Materials
ORGN
$155K ﹤0.01%
1,211
-16,397
-93% -$2.11M
AVAL icon
5147
Grupo Aval
AVAL
$6.11B
$154K ﹤0.01%
66,511
+55,458
+502% +$132K
TOP icon
5148
TOP Financial Group
TOP
$1.31B
$154K ﹤0.01%
16,429
-13,127
-44% -$169K
LIDR icon
5149
AEye
LIDR
$52.8M
$154K ﹤0.01%
+28,416
New +$176K
THCH icon
5150
CALL
TH International
THCH
$57M
$154K ﹤0.01%
+10,700
New +$192K

Similar funds

Millennium Management's Q2 2023 Portfolio in Review

As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
  • Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.